PBE
Invesco Biotechnology & Genome ETF·NYSE
--
--(--)
--
--(--)
Key Stats
Assets Under Management
268.12MUSD
Fund Flows (1Y)
-29.42MUSD
Dividend Yield
0.98%
Discount/Premium to NAV
0.05%
Shares Outstanding
3.21M
Expense Ratio
0.58%
About Invesco Biotechnology & Genome ETF
Issuer
--
Brand
--
Home Page
--
Inception Date
--
Structure
--
Index Tracked
--
Management Style
--
Dividend Treatment
--
Distribution Tax Treatment
--
Income Tax Type
--
Max ST Capital Gains Rate
--
Max LT Capital Gains Rate
--
Primary Advisor
--
Distributor
--
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Biotechnology
Strategy
Multi-factor
Geography
U.S.
Weighting Scheme
Tiered
Selection Criteria
Multi-factor
Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Holdings
Symbol
Ratio
GILD
Gilead Sciences
5.89%
AMGN
Amgen
5.43%
ILMN
Illumina
5.24%
BIIB
Biogen
5.18%
REGN
Regeneron
4.97%
UTHR
United Therapeutics
4.96%
Symbol
Ratio
INCY
Incyte
4.78%
FOLD
Amicus Therapeutics
3.89%
ALNY
Alnylam Pharmaceuticals
3.77%
DVAX
Dynavax Technologies
3.65%
Top 10 Weight 47.76%
10 Total Holdings
See all holdings
Related Funds
BBC
Virtus LifeSci Biotech Clinical Trials ETF0
+0.00%
PSIL
AdvisorShares Psychedelics ETF0
+0.00%
LABU
Direxion Daily S&P Biotech Bull 3X Shares0
+0.00%
HELX
Franklin Genomic Advancements ETF0
+0.00%
IDNA
iShares Genomics Immunology and Healthcare ETF0
+0.00%
ARKG
ARK Genomic Revolution ETF0
+0.00%
HRTS
Tema Heart & Health ETF0
+0.00%
SBIO
ALPS Medical Breakthroughs ETF0
+0.00%
Seasonals
Volume Profile
Trade Flow Insight
Community Forum
Loading...
Related News
No articles available
You can ask Aime
No Data
